1 |
Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis. Genes Dev. 1999 ; 13 : 239-52.
DOI
ScienceOn
|
2 |
Fini ME, Cook JR, Mohan R. Regulation of matrix metalloproteinase gene expression. Matrix Metalloproteinases (Edited by Parks WC Mecham RP). San Diego : Academic Press. 1998 ; 299-356.
|
3 |
Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Structure, function, and biochemistry. Circ Res. 2003 ; 92 : 827-39.
DOI
ScienceOn
|
4 |
HS Lee, HS Song. Bee venom inhibits LNCaP cell proliferation through induction of apoptosis via inactivation of NF- B. Journal of Acupuncture and Moxibustion. 2007 ; 25(2) : 59-74.
|
5 |
Dasmahapatra GP, Didolkar P, Alley MC, Ghosh S, Sausville EA, Roy KK. In vitro combination treatment with perifosine and UCN-01 demonstrates synergism against prostate (PC-3) and lung (A549) epithelial adenocarcinoma cell lines. Clin Cancer Res. 2004 ; 10 : 5242-52.
DOI
ScienceOn
|
6 |
Sedlak TW, Oltvai ZN, Yang E et al. Multiple Bcl2 family members demonstrate selective dimerization with Bax. Proc. Natl. Acad. Sci. USA. 1995 ; 92 : 7834-8.
DOI
ScienceOn
|
7 |
Reed JC. Apoptosis-based therapies. Nat Rev Drug Discov. 2002 ; 1 : 11121.
|
8 |
Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2002 ; 2 : 647-56.
|
9 |
Gurumurthy S, Vasudevan KM, Rangnekar VM. Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev. 2001 ; 20 : 22543.
|
10 |
Kantoff PW. New agents in the therapy of hormone-refractory patients with prostate cancer. Semin Oncol. 1995 ; 22(1) : 324.
|
11 |
Simon HU, Haj-Heyia A, Levi Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2000 ; 5 : 415-8.
DOI
ScienceOn
|
12 |
Thornberry NA, Lazbrik Y. Caspases : enemies within. Science. 1998 ; 281 : 1312-6.
DOI
|
13 |
HJ Oh, HS Song. Bee Venom Inhibits PC-3 Cell Proliferation Through Induction of Apoptosis Via Inactivation of NF- B. Journal of Korean Acupuncture and Moxibustion. 2010 ; 27(3) : 1-13.
|
14 |
Benimetskaya L, Miller P, Benimetsky S et al. Inhibition of potentially anti-apoptotic proteins by antisense protein kinase C-alpha (Isis 3521) and antisense bcl-2 (G3139) phosphorothioate oligodeoxynucleotides: relationship to the decreased viability of T24 bladder and PC3 prostate cancer cells. Mol Pharmacol. 2001 ; 60 : 129630-7.
|
15 |
Bettaieb A, Dubrez-Daloz L, Launay S et al. Bcl-2 proteins: targets and tools for chemosensitisation of tumor cells. Curr Med Chem AntiCancer Agents. 2003 ; 3 : 307-18.
DOI
ScienceOn
|
16 |
Wyllie AH. The genetic regulation of apoptosis. Curr. Opin. Genet.Dev. 1995 ; 5(1) : 97-104.
DOI
ScienceOn
|
17 |
Green DR, Reed JC. Mitochondria and Apoptosis. Science. 1998 ; 281 : 1309-12.
DOI
|
18 |
Nachshon-Kedmi M, Yannai S, Fares FA. Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3'-diindolylmethane through the mitochondrial pathway. Br J Cancer. 2004 ; 91 : 1358-63.
DOI
ScienceOn
|
19 |
Darmon AJ, Nicholson DW, Bleackley RC. Activation of the apoptotic proteaseCPP32 by cytotoxic T cell derived granzyme B. Nature. 1995 ; 377 : 446-8.
DOI
ScienceOn
|
20 |
Zu K, Ip C. Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells. Cancer Res. 2003 ; 63 : 6988-95.
|
21 |
K Abdelmohsen, R Pullmann Jr, A Lal, HH Kim, S Galban, X Yang, JD Blethrow, M Walker, J Shubert, DA Gillespie, H Furneaux, M Gorospe. Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell. 2007 ; 25 : 543-57.
DOI
ScienceOn
|
22 |
Y Akao, S Kusakabe, Y Banno, M Kito, Y Nakagawa, K Tamiya-Koizumi, M Hattori, M Sawada, Y Hirabayasi, N Ohishi, Y Nozawa. Ceramide accumulation is independent of camptothecin- induced apoptosis in prostate cancer LNCaP cells. Biochem Biophys Res Commun. 2002 ; 294 : 363-70.
DOI
ScienceOn
|
23 |
Y Akao, Y Banno, Y Nakagawa, N Hasegawa, TJ Kim, T Murate, Y Igarashi, Y Nozawa. High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecininduced up-regulation. Biochem Biophys Res Commun. 2006 ; 342 : 1284-90.
DOI
ScienceOn
|
24 |
K Mizutani, K Matsumoto, N Hasegawa, T Deguchi, Y Nozawa. Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT-sensitive LNCaP cells. Exp Oncol. 2006 ; 28 : 209-15.
|
25 |
Singh AV, Xiao D, Lew KL, Dhir R, Singh SV. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis. 2004 ; 25 : 83-90.
|
26 |
Pugazhenthi S, Nesterova A, Sable C, Heideich KA, Boxer LM, Heasley LE, Rensch JEB. Akt/ protein kinase B upregulates Bcl2 expression through cAMP-response element-binding protein. J Biol Chem. 2000 ; 275 : 10761-6.
DOI
|
27 |
Cardone MH, Roy N, Stennicke HR, Salvesen GS, Frarke TF, Stanbridge E, Frisch S, Reed JC. Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998 ; 282 : 1318-21.
DOI
|
28 |
LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 1998 ; 17 : 3247-59.
|
29 |
Nesterov A, Ivashchenko Y, Kraft AS. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells. Oncogene. 2002 ; 21 : 1135-40.
DOI
ScienceOn
|
30 |
Holle L, Song W, Holle E, Wei Y, Wagner T, Yu X. A matrix metalloproteinase 2 cleavable melittin/avidin conjugate specifically targets tumor cells in vitro and in vivo. Int J Oncol. 2003 ; 22 : 93-8.
|
31 |
HJ Park, YK Lee, HS Song, KJ Kim, DJ Son, JW Lee and JT Hong. Melittin inhibits human prostate cancer cell growth through induction of apoptotic cell death. J Toxicol Pub Health. 2006 ; 22(1) : 31-7.
|
32 |
Keitaro K, Riyako O, Yasunori F, Nanako H, Yukihiro A, Yoshinori N, Takashi D, Masafumi I. A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. Biochemical and Biophysical Research Communications. 2008 ; 373 : 423-8.
DOI
ScienceOn
|
33 |
Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000 ; 21 : 48595.
|
34 |
Guseva NV, Taghiyev AF, Rokhlin OW, Cohen MB. Death receptor-induced cell death in prostate cancer. J Cell Biochem. 2004 ; 91 : 7099.
|
35 |
Sun M, Wang G, Paciga JE, Feldman RI, Yuan ZQ, Ma XL et al. AKT1/PKB alpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol. 2001 ; 159(2) : 431-7.
DOI
ScienceOn
|
36 |
YB Kwon, HJ Lee, HJ Han, WC Mar, SK Kang, OB Yoon, Beitz AJ, JH Lee. The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sci. 2002 ; 71 : 191-204.
DOI
ScienceOn
|
37 |
Jemal A, Tiwari RC, Murray T et al. Cancer Statistics. CA Cancer J Clin 2005 ; 55 : 10-30.
DOI
ScienceOn
|
38 |
Schally AV, Comaru-Schally AM, Plonowski A et al. Peptide analogs in the therapy of prostate cancer. Prostate. 2000 ; 45 : 158-66.
DOI
ScienceOn
|
39 |
Cai RZ, Qin Y, Ertl T et al. New pseudononapeptide bombesin antagonist with C-terminal LeuW (CH2N)Tac-NH2 showing high binding affinity to bombesin/GRP receptors on CFPAC-1 human pancreatic cancer cell line. Int J Oncol. 1995 ; 6 : 1165-72.
|